Single-cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib

Purroy, Noelia, Tong, Yuzhou Evelyn, Lemvigh, Camilla K., Cieri, Nicoletta, Li, Shuqiang, Parry, Erin M., Zhang, Wandi, Rassenti, Laura Z., Kipps, Thomas J., Slager, Susan L., Kay, Neil E., Lesnick, Connie, Shanafelt, Tait D., Ghia, Paolo, Scarfò, Lydia, Livak, Kenneth J., Kharchenko, Peter V., Neuberg, Donna S., Olsen, Lars Rønn, Fan, Jean, Gohil, Satyen H., Wu, Catherine J.